Pan-Cancer Liquid Biopsy and Treatment Monitoring via a Split crRNA-Activated Label-Free CRISPR/Cas12a Platform for Ultrasensitive MicroRNA Detection
Analytical Chemistry · 2026
DOI: 10.1021/acs.analchem.6c02601 ↗Kurz gefasst
Fachartikel in der Zeitschrift Analytical Chemistry, 2026. Verfasst von Yixia Yang und 10 weiteren Autor:innen. Beteiligte Einrichtung: Guangdong Provincial Key Laboratory of Digestive Cancer Research, Department of Oncology, Department of Dermatovenereology, The Biobank, Scientific R…. Hauptthemen laut MEDLINE: MicroRNAs, Liquid Biopsy, Neoplasms. Die Arbeit wurde bisher 1-mal zitiert (Crossref) und nennt 55 Literaturangaben. Gefördert von: Special Project for Research and Development in Key areas of Guangdong Province, Basic and Applied Basic Research Foundation of Guangdong Province, Shenzhen Medical Research Fund.
Abstract (Originalsprache)
Kein Abstract verfügbar.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Substanzen
Autor:innen und Institutionen
- Guangdong Provincial Key Laboratory of Digestive Cancer Research, Department of Oncology, Department of Dermatovenereology, The Biobank, Scientific Research Center, The Seventh Affiliated Hospital, School of Medicine, S…
- Gastrointestinal Hernia Surgery, Jiangxi Provincial People's Hospital, The First Affiliated Hospital of Nanchang Medical College, Nanchang 330006, China.
- School of Biomedical Engineering, Sun Yat-Sen University, Shenzhen Campus of Sun Yat-Sen University, Shenzhen 518107, China.
Förderung
- Special Project for Research and Development in Key areas of Guangdong Province
- Basic and Applied Basic Research Foundation of Guangdong Province
- Shenzhen Medical Research Fund
- Shenzhen Science and Technology Innovation Commission
- National Natural Science Foundation of China (NSFC)
- Seventh Affiliated Hospital, Sun Yat-sen University
Zitieren
APA
Yang, Y., Pan, Q., Liu, M., Zeng, L., Zou, H., Liu, S., Fu, S., Xu, Y., Dai, Z., Fang, S., & Pan, Y. (2026). Pan-Cancer Liquid Biopsy and Treatment Monitoring via a Split crRNA-Activated Label-Free CRISPR/Cas12a Platform for Ultrasensitive MicroRNA Detection. Analytical Chemistry. https://doi.org/10.1021/acs.analchem.6c02601
Vancouver
Yang Y, Pan Q, Liu M, Zeng L, Zou H, Liu S, et al. Pan-Cancer Liquid Biopsy and Treatment Monitoring via a Split crRNA-Activated Label-Free CRISPR/Cas12a Platform for Ultrasensitive MicroRNA Detection. Analytical Chemistry. 2026. doi:10.1021/acs.analchem.6c02601
BibTeX
@article{Yang2026,
author = {Yang, Yixia and Pan, Qingming and Liu, Minling and Zeng, Leli and Zou, Hailin and Liu, Shuhao and Fu, Shuying and Xu, Yuzhi and Dai, Zong and Fang, Shuo and Pan, Yihang},
title = {Pan-Cancer Liquid Biopsy and Treatment Monitoring via a Split crRNA-Activated Label-Free CRISPR/Cas12a Platform for Ultrasensitive MicroRNA Detection},
journal = {Analytical Chemistry},
year = {2026},
doi = {10.1021/acs.analchem.6c02601}
}
EUVIMED